Wireless Blood Glucose Meter Market Report: Production, Revenue, Price, Share and Growth Rate11/3/2017 Rising awareness and development of self-monitoring blood glucose meters can boost demand in the years to come. Developing economies have a huge market potential on account of a large patient pool and low market penetration of the existing devices. Carematix Wellness Systems recently launched its OneTouch Ultra device. It can track blood sugar readings remotely and store all the necessary data regarding food, medication, and stress levels. This allows consumers to track their glucose levels on a daily basis. Request a Free Sample Copy of this Report @ https://www.radiantinsights.com/research/global-wireless-blood-glucose-meter-market-professional-survey-report-2017/request-sample The US Food & Drug Administration (FDA) has given 510 (k) clearance to the OneTouch Verio Flex glucometer by Johnson & Johnson (J&J) for its integration with BlueStar diabetes management platform by WellDoc. This product can reflect blood sugar readings through a range of color indicators. It can be installed on the mobile devices. The device can also send guided plans according to the readings. The US Food & Drug Administration (FDA) has given 510 (k) clearance to the OneTouch Verio Flex glucometer by Johnson & Johnson (J&J) for its integration with BlueStar diabetes management platform by WellDoc. This product can reflect blood sugar readings through a range of color indicators. It can be installed on the mobile devices. The device can also send guided plans according to the readings. For further inquiries, about - Global Industry Analysis, Size, Growth, Trends and Forecast 2017 - 2021, click on this link – https://www.radiantinsights.com/research/global-wireless-blood-glucose-meter-market-professional-survey-report-2017 The worldwide wireless blood glucose meter market is segmented on the basis of types, applications, and regions. By types, the market is bifurcated into manual and automatic blood glucose meters. The latter enjoys greater popularity due to its user-friendly system. Major market applications comprise physical examination centers, hospitals, and clinics. Hospitals are expected to garner major market share over the forecast period. Assistance in detecting diabetes at an early stage can propel the demand. Data samples obtained from these tests can act as a precursor for better drugs and antibiotics. The global wireless blood glucose meter market is anticipated to attain impressive revenue by 2022, according to a report available on Radiant Insights, Inc. High prevalence of diabetes and adoption of sugar level surveillance systems are the key market drivers. Diabetes is one of the leading causes of deaths around the world. Fast-paced lifestyles imbued with poor dietary habits can cause diabetes. Rapidly growing elderly population and prevalence of diabetes is anticipated to impel blood glucose meter sales in the forthcoming years. Geographically, the global wireless blood glucose meter market is divided into Southeast Asia, Europe, United States, India, China, and Japan. United States is expected to lead the global market in the years to come. Availability of the latest technology, increased healthcare per capita, supportive reimbursement policies, and huge patient pool are the key regional growth drivers. China on the other hand, is expected to exhibit a high CAGR, followed by India and Japan. Key market players include Abbott Diabetes Care, F. Hoffmann-La Roche AG, Nova Biomedical, ForaCare Suisse AG, and General Life Biotechnology Co., Ltd. Product launches and innovations are some of the chief business expansion strategies undertaken by most companies to sustain market hold. For instance, Roche’s Accu-Chek Guide blood glucose monitoring system (BGMS) offers a vial to take a blood sample. It also has wireless connectivity to save data on the connected mobile application.
0 Comments
A CTG test is prescribed during the third trimester of pregnancy. It can measure Braxton Hicks contractions that indicate labor. Cardiotocography is usually prescribed if a woman is expecting twins, has low amniotic fluid, and is suffering from placental complications, hypertension, or diabetes. It is sometimes performed during labor when the unborn baby requires continuous monitoring.
Request a Free Sample Copy of this Report @ www.radiantinsights.com/research/global-cardiotocograph-ctg-industry-2017/request-sample Increased governmental and non-governmental initiatives for fetal and maternal health are the key market drivers. Growing awareness and willingness of the key manufacturers to invest in research & development can further support the CTG market in the years to come. CTG is the best way to assess fetal health both before birth and during labor. Advancing technologies have increased the demand for EFM systems over the past few years. Cardiotocography is a diagnostic test that can check uterine contractions and fetal heartbeat during pregnancy. The instrument used to perform this test is called cardiotocograph. It is also known as Electronic Fetal Monitor (EFM). According to a report made available by Radian Insights, Inc.; the cardiotocograph (CTG) market in the United States is anticipated to witness a healthy CAGR over the forecast period (from 2017 to 2022). Download Full Research Report of Global Cardiotocograph (CTG) Market @ www.radiantinsights.com/research/global-cardiotocograph-ctg-industry-2017 The WatchChild fetal monitoring system is a fully configurable, comprehensive, and incorporated perinatal data management system. It is designed to simplify the information management process during delivery. It allows caregivers to get a closer look and to ensure safety of the mother and her child. Its decision support systems present essential data that can be vital in emergencies. Assembled on an open architecture, this fetal monitoring solution provides integration capabilities for accurate and immediate bidirectional information exchange with the help of the Electronic Medical Record (EMR). In addition, its exclusive Data Acquisition System (DAS) can capture information even if the hospital’s network is not available. Such “store-and-forward” data storage systems can store four days of data. DAS forwards this data directly to the EMR system as soon as it is ready. The cardiotocograph (CTG) market in the United States is categorized into product types, applications or end-users, and regions. On the basis of product types, the market is split into traditional and intelligent cardiotocograph. According to applications, the market is segregated into clinical, hospital, and home. Regional segmentations are New England, Mid-Atlantic, Southwestern, Midwestern, Southern, and Western United States. Prominent companies operating in the cardiotocograph (CTG) market are Philips Healthcare; GE Healthcare; Contec Medical Systems Co. Ltd.; Shenzhen Luckcome Technology Inc.; and Huntleigh Healthcare. Adoption of wearable technology, mobile monitoring and other such innovative methods are expected to boost research & development activities in the global market. This factor is expected to create growth opportunities for the key manufacturers. Rapid advancements in cardiotocograph systems and novel technologies are expected to impel the regional market growth. Keeping up with such developments is a major challenge for the major market manufacturers. Thus, most key market players adopt various business strategies to attain higher market position. These strategies include novel product launches, research & development, regional and product portfolio expansions, and mergers & acquisitions. |
Archives
December 2023
Categories |